NEW YORK (GenomeWeb News) - Illumina said today it will develop a custom SNP microarray for the study of vascular diseases through a "multi-million dollar" collaboration with the Institute of Translational Medicine and Therapeutics at the University of Pennsylvania, the Broad Institute, and the National Heart, Lung, and Blood Institute's Candidate-gene Association Resource (CARe) Consortium.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.